President Donald Trump ordered administration officials to draw up a list of 26 key drugs to develop a stockpile in the ...

The interleukin-23 inhibitors market is witnessing robust growth driven by the rising prevalence of autoimmune diseases like psoriasis and in ...

The outlook for the neuroblastoma treatment market is optimistic, fueled by progress in targeted therapies and immunotherapies. GD2-targeted ...